TipRanks
Chemomab Therapeutics (DE:2QV)
FRANKFURT:2QV

Compare Chemomab Therapeutics (2QV) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Chemomab Therapeutics
€2.94
€9.09M
-1.37
0.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
Tenax Therapeutics
$2.32
$73.35M
-1.30
-74.80%
6 Buy
4 Hold
0 Sell
Moderate Buy
Q32 Bio
$16.32
$249.17M
2.91
273.73%
7 Buy
0 Hold
0 Sell
Strong Buy
Passage Bio
$4.52
$13.16M
-0.36
-48.55%
0 Buy
1 Hold
0 Sell
Hold
CalciMedica
$0.59
$10.52M
-0.22
-90.83%
1 Buy
1 Hold
0 Sell
Moderate Buy
Longeveron
$0.68
$8.00M
-0.23
-70.27%
1 Buy
1 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:2QV
Chemomab Therapeutics
2.94
0.00
0.00%
TENX
Tenax Therapeutics
1.93
-5.90
-75.35%
QTTB
Q32 Bio
8.11
5.12
171.24%
PASG
Passage Bio
4.08
-4.20
-50.72%
CALC
CalciMedica
1.49
-14.44
-90.65%
LGVN
Longeveron
2.35
-6.92
-74.65%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts